Xellia Pharmaceuticals US FDF Business and Related Assets
Sector: Commercial • Location: Cleveland, Ohio, USA
Source: Financial Conduct Authority (FCA)
Acquisition of Xellia Pharmaceuticals' US finished dosage form business including a manufacturing facility in Cleveland, Ohio, commercial portfolio, pipeline, sales and marketing capabilities, and an R&D center in Zagreb, Croatia. The acquisition supports growth of Hikma's Injectables business and expands manufacturing capacity and technologies.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | Obfuscated Data |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Acquisition of Xellia Pharmaceuticals' US finished dosage form business including a manufacturing facility in Cleveland, Ohio, commercial portfolio, pipeline, sales and marketing capabilities, and an R&D center in Zagreb, Croatia. The acquisition supports growth of Hikma's Injectables business and expands manufacturing capacity and technologies. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |